EcoR1 Capital, LLC
Q3 2026 13F-HR Holdings
Net value change ($000)
+195,838
(9.5%)
New positions
9
Sold out positions
5
Turnover %
11.6%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2026
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| ANRO | 56,983 | NEW |
| FIRST TRACKS BIOTHERAPEUTICS | 48,634 | 76.1% |
| ETON | 48,604 | 61.8% |
| ERAS | 37,201 | 615.3% |
| ATTOVIA THERAPEUTICS INC | 34,692 | NEW |
| CGON | 26,528 | 25.0% |
| ADARX PHARMACEUTICALS INC | 22,931 | NEW |
| ELECTRA THERAPEUTICS INC | 19,125 | NEW |
| CAPR | 13,036 | NEW |
| XNCR | 12,475 | NEW |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
218,407
(9.7% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|